Home Medicine Haemorrhagic and thrombotic complications in pregnant women with acquired and congenital cardiac disease
Article
Licensed
Unlicensed Requires Authentication

Haemorrhagic and thrombotic complications in pregnant women with acquired and congenital cardiac disease

  • Barry Kevane , Peter McKenna , Kevin Walsh , Jennifer C. Donnelly , Karen Flood , Michelle Cullen , Mary Bowen , Patrick Thornton , John Loughrey , Sam Coulter-Smith and Fionnuala Ní Áinle EMAIL logo
Published/Copyright: July 11, 2014

Abstract

Background: Pregnant patients with cardiac disease have significantly higher predicted maternal morbidity and mortality compared to the general obstetric population. Published guidelines on optimal management of these patients recommend multidisciplinary care provision. There are few published data on the incidence of haematological complications in pregnant women with cardiac disease, although the data that does exist suggests a relatively high rate of bleeding and thrombotic events.

Aims: To determine the outcomes in terms of haematological morbidity occurring within a cohort of pregnant women with cardiac disease in the setting of multidisciplinary care provision.

Methods: Patients were identified from a database compiled by the obstetric cardiology service listing all cardiac patients managed in the Rotunda maternity hospital during the period from 2004 to 2011. Data were obtained from the medical and obstetric case notes relating to details of perinatal care and the occurrence of antenatal and postnatal complications.

Results: During the 8-year review period, 451 women with cardiac disease were assessed. Fifty-nine were determined to have moderate to high-risk disease. Each received consultant-delivered multidisciplinary care, where written management strategies were agreed by collaborating senior colleagues either preconceptually or in early pregnancy. No venous thromboembolic events occurred and a modest rate of post-partum haemorrhage (approximately 5%) was recorded. There were no maternal deaths.

Conclusion: The relatively favourable outcomes observed within our institution highlight the importance of a multidisciplinary approach to the management of pregnant women with cardiac disease, particularly in scenarios where limited published evidence exists to guide management.


Corresponding author: Fionnuala Ní Áinle, Rotunda Hospital, Parnell St, Dublin 1, Ireland; and Mater Misericordiae University Hospital, Dublin 7, Ireland, E-mail: ; and Department of Haematology, Rotunda Hospital, Dublin, Ireland; and Mater Misericordiae University Hospital, Dublin, Ireland

Acknowledgments

The authors would like to acknowledge the support of the “Friends of the Rotunda” charity and the Health Research Board of Ireland (Health research award R13728).

References

[1] Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141 (Suppl 2):e691S–736S.10.1378/chest.11-2300Search in Google Scholar PubMed PubMed Central

[2] Bowater SE, Thorne SA. Management of pregnancy in women with acquired and congenital heart disease. Postgrad Med J. 2010;86:100–5.10.1136/pgmj.2008.078030Search in Google Scholar PubMed

[3] Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. Am J Obstet Gynecol. 2010;202:353.e1–6.10.1016/j.ajog.2010.01.011Search in Google Scholar PubMed

[4] Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1–203.10.1111/j.1471-0528.2010.02847.xSearch in Google Scholar PubMed

[5] Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.10.1093/eurheartj/ehq200Search in Google Scholar PubMed

[6] Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007;49:2303–11.10.1016/j.jacc.2007.03.027Search in Google Scholar PubMed

[7] Head CE, Thorne SA. Congenital heart disease in pregnancy. Postgrad Med J. 2005;81:292–8.10.1136/pgmj.2004.026625Search in Google Scholar PubMed PubMed Central

[8] Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a register-based case-control study. Am J Obstet Gynecol. 2008;198:233.e1–7.10.1016/j.ajog.2007.08.041Search in Google Scholar PubMed

[9] James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311–5.10.1016/j.ajog.2005.11.008Search in Google Scholar PubMed

[10] Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation. 2006;113:517–24.10.1161/CIRCULATIONAHA.105.589655Search in Google Scholar PubMed

[11] Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98:254–8.10.1016/j.amjcard.2006.01.083Search in Google Scholar

[12] Lu MC, Fridman M, Korst LM, Gregory KD, Reyes C, Hobel CJ, et al. Variations in the incidence of postpartum hemorrhage across hospitals in California. Matern Child Health J. 2005;9:297–306.10.1007/s10995-005-0009-3Search in Google Scholar

[13] McLintock C. Obstetric haemorrhage. Thromb Res. 2009;123(Suppl 2):S30–4.10.1016/S0049-3848(09)70006-4Search in Google Scholar

[14] McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin. BJOG. 2009;116: 1585–92.10.1111/j.1471-0528.2009.02299.xSearch in Google Scholar PubMed

[15] Ouyang DW, Khairy P, Fernandes SM, Landzberg MJ, Economy KE. Obstetric outcomes in pregnant women with congenital heart disease. Int J Cardiol. 2010;144:195–9.10.1016/j.ijcard.2009.04.006Search in Google Scholar PubMed

[16] Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Royal College of Obstetricians and Gynaecologists Green-top Guideline No 37a; 2009.Search in Google Scholar

[17] Simpson EL, Lawrenson RA, Nightingale AL, Farmer RD. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56–60.Search in Google Scholar

[18] Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–21.10.1161/hc3001.093437Search in Google Scholar PubMed

[19] Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood. 2013;121:3953–61.10.1182/blood-2012-11-469551Search in Google Scholar PubMed

[20] Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008;118:2395–451.10.1161/CIRCULATIONAHA.108.190811Search in Google Scholar PubMed

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2014-3-12
Accepted: 2014-6-13
Published Online: 2014-7-11
Published in Print: 2015-3-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Academy’s Corner
  3. Obstetrical Doppler: the evidence today
  4. Review article
  5. Fetal complications due to intrahepatic cholestasis of pregnancy
  6. Original articles – Obstetrics
  7. Pre-pregnancy obesity compromises obstetric and neonatal outcomes
  8. Novel application of three-dimensional HDlive imaging in prenatal diagnosis from the first trimester
  9. Placental gene expression of inflammatory markers and growth factors – a case control study of obese and normal weight women
  10. Haemorrhagic and thrombotic complications in pregnant women with acquired and congenital cardiac disease
  11. Intrapartum ultrasound prior to Kristeller maneuver: an observational study
  12. Interinstitutional variations in mode of birth after a previous caesarean section: a cross-sectional study in six German hospitals
  13. Use of the angle of progression on ultrasonography to predict spontaneous onset of labor within 7 days
  14. Study of the relationship in pregnant women between hepatitis B markers and a placenta positive for hepatitis B surface antigen
  15. Sarcoidosis and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 7 million births
  16. Original articles – Fetus
  17. MR imaging of the fetal brain at 1.5T and 3.0T field strengths: comparing specific absorption rate (SAR) and image quality
  18. Sex differences in the fetal heart rate variability indices of twins
  19. Original articles – Newborn
  20. Correlation of neonatal weight with maternal serum levels of pregnancy-associated plasma protein-A during the first trimester of pregnancy: a retrospective study
  21. Antenatal testing in uncomplicated pregnancies: should testing be initiated after 40 or 41 weeks?
  22. Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection
  23. Associated anomalies in congenital diaphragmatic hernia: perinatal characteristics and impact on postnatal survival
  24. The value of lipopolysaccharide binding protein for diagnosis of late-onset neonatal sepsis in very low birth weight infants
  25. Is there a stepwise increase in neonatal morbidities according to histological stage (or grade) of acute chorioamnionitis and funisitis?: effect of gestational age at delivery
  26. Commentary
  27. Thrombophilia testing in pregnancy: should we agree to disagree?
  28. Congress Calendar
  29. Congress Calendar
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2014-0088/html
Scroll to top button